AugustineA Onyeaghala

AugustineA Onyeaghala

Auto-generated profile, based on publicly available information

AugustineA Onyeaghala

Chrisland University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2023 in Scientific African
Verified
Journal Article
Open access
AOAugustine Anayochukwu Onyeaghala
Augustine Anayochukwu Onyeaghala
AAArinze Favour Anyiam
Arinze Favour Anyiam
DHDanladi Chiroma Husaini
Danladi Chiroma Husaini
EOEmmanuella Ogechi Onyeaghala
Emmanuella Ogechi Onyeaghala
EOEjeatuluchukwu Obi
Ejeatuluchukwu Obi
The advent of Corona virus Disease 2019 (COVID-19) distorted health systems of many countries. Efforts have been made to either develop new treatment solutions such as vaccines or repurpose previously adopted drugs. Challenges in accessing available treatment, inadequate, non-existent, or overstretched healthcare facilities, long COVID disease, cultural practices and beliefs about vaccination, vaccine hesitancy, availability, accessibility and perceived safety of herbal supplements seem to be major factors propelling individuals to use herbal supplements. Published reports advocating for clinical development of herbal supplements for COVID-19 and other emerging and re-emerging viral diseases are sparse. This paper aims to review the pathogenesis of COVID-19, use of herbal products during the pandemic and make case for clinical development of herbal supplements through the adoption of modern and acceptable technologies and research processes. This was a scoping review. Database searches of Google Scholar, PubMed and ResearchGate among others were performed using related keywords to identify relevant journals and lists of primary articles. Clinical trial databases:-Clinicaltrial.gov, Pan African Clinical Trial Registry (PACTR) and WHO international clinical trial registry (ICTRP) were reviewed to extract data. The use of herbal supplements during COVID-19 was not only peculiar to individuals living in Sub-Saharan Africa, but a global practice. Herbal supplements recommended to manage COVID-19 have not been validated using clinical trials. Available data showed that the number of herbal supplements undergoing clinical trial for COVID-19 indication in Africa was low. The availability of medicinal plants in Sub-Saharan Africa if well explored has great potentials to address various emerging and re-emerging viral diseases confronting the region. The economic potential of clinically validated herbal supplements are huge, and tapping into this opportunity created by preference of population to herbal supplement could increase export of herbal supplement and gross domestic product (GDP) of respective countries in Africa.

7 February 2020 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
PDF file
AOAugustine Anayochukwu Onyeaghala
Augustine Anayochukwu Onyeaghala
IOIsiramen Olajide
Isiramen Olajide
Severe Acute Respiratory Syndrome – novel Coronavirus 2 (SARS-nCoV-2), was first reported in Wuhan, China, in December, 2019. Since the outbreak, the virus has infected more than 9,866,685 individuals, 4,983,029 treated and discharged and 495,692 deaths globally. The first Coronavirus Disease 2019 (COVID-19) in Nigeria was imported in February, 2020 and since then community transmission has been prevalent. As at the time of writing this report, Nigeria has reported about 23,298 cases of COVID-19, 8,253 treated and discharged and 554 deaths, giving a case mortality ratio of 2.4%. While responsible government agencies and international partners have been working hard to curtail the spread of the disease, we present in this report, some matters arising from managing COVID-19 pandemic in Nigeria; and proffered suggestions which could help not only in managing the current COVID-19 pandemic, but also for winning future outbreaks of public health significance with a view to curtailing global health security.

18 February 2005 in West Africa Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MEMo Ebesunun
Mo Ebesunun
BSBa Solademi
Ba Solademi
OSOb Shittu
Ob Shittu
JAJi Anetor
Ji Anetor
JOJa Onuegbu
Ja Onuegbu
AOAa Onyeaghala
Aa Onyeaghala
Plasma and semen ascorbic levels in spermatogenesis

31 October 2016 in African Journal of Food Science
Verified
Journal Article
Open access
PDF file
AOA A Onyeaghala
A A Onyeaghala
III F Ijagbone
I F Ijagbone
OKO Chima Kalu
O Chima Kalu
Tomato paste is consumed in many homes. It is a good source of lycopene and vitamin C. These are antioxidants which fight against free radicals and oxidative stress. It had been reported that tomato pastes imported into Nigeria were often substandard and adulterated with starch, but these claims have not been supported using evidence based study. The aim of the study was to assess the quality of different tomato brands made in Nigeria and those imported into the country using biochemical parameters. Twenty eight different tomato products were identified in the market. Of these numbers, sixteen were randomly selected. Five tins and sachets each of these products were purchased respectively and used for analyses. All the products sampled were registered with the National Agency for Food and Drug Administration and Control. There were significant differences in moisture, Lycopene, total sugar, starch, vitamin C and acidity among all products (P0.05). However, tomato brands imported from China were significantly higher in total sugar and starch, but significantly lower in lycopene (P< 0.05). Variations in content were observed between tin and sachet of the same brand and between different batches of the same product. This study provides scientific evidence that tomato products made in Nigeria are better in biochemical quality than products imported from China. The need to patronize and support local manufacturers while tightening regulatory and registration processes of products imported into the country becomes imperative. Key words: Tomato, quality assurance, biochemical analysis, Free radicals, oxidative stress, antioxidants.

10 May 2021 in Journal of Complementary and Integrative Medicine
Verified
Journal Article
Closed access
AOAugustine Anayochukwu Onyeaghala
Augustine Anayochukwu Onyeaghala
EOEmmanuella Ogechi Onyeaghala
Emmanuella Ogechi Onyeaghala
CBChinedum Peace Babalola
Chinedum Peace Babalola
OAOluwasanmi Olayinka Aina
Oluwasanmi Olayinka Aina
DJDadik Jelpe
Dadik Jelpe
Objective: To explore repurposing known natural products for managing patients with mild to moderate symptoms of COVID-19. Case presentation: We present a case report of a middle aged woman, who was positive to COVID 19, with mild to moderate symptoms; who self –managed at home using well formulated herbal supplement (Combi-5) taken along with vitamin C and Zinc supplements. She recovered within a short time. Conclusions: While we may not conclude from this report that Combi-5 was solely responsible for the recovery of the patient, we strongly believe that it played significant role through different mechanisms in facilitating early recovery from the infection. Further studies are needed to evaluate the phytochemical and pharmacological constituents of the supplement; investigate its direct effect(s) on SARS CoV-2 and conduct randomized controlled trial to elucidate its clinical benefits.

10 January 2015 in European Journal of Medicinal Plants
Verified
Journal Article
Open access
PDF file
AOA. A. Onyeaghala
A. A. Onyeaghala
IOI. O. Omotosho
I. O. Omotosho
ASA. R. Shivashankara
A. R. Shivashankara
Aims: To investigate cytotoxicity of pure fractions of compounds extracted from yoyo bitters on human cervical cancer cell and to characterize the compounds present in various extracts. Study Design: Experimental Study. Background: Cervical cancer is one of the leading causes of death. It is common among women of reproductive age and it causes the highest morbidity and mortality among this population. In spite of several researches, therapeutic cure for cancer using conventional therapies has been elusive and this has resulted in the use of alternative therapies. Yoyo Bitters (YYB), a herbal product, produced in Nigeria is widely consumed with a view to alleviating various health challenges. Previous studies using animal models have tried to elucidate the pharmacological activities of YYB, but none has explored its cytotoxicity against human cervical cancer cells. This study was designed to investigate the cytotoxicity of pure fractions of compounds extracted from yoyo bitters on human cervical cancer cell and to characterize the compounds present in various extracts. Materials and Methods: Pure extracts of YYB were obtained using Column Chromatography. These extracts were investigated in vitro on Human Cervical Cancer Cells (Hela) with low passage number using MTT assay. Chemical compounds present in the extracts were characterized using Gas Chromatography, Mass Spectrometry (GC-MS). Results: showed that various fractions of YYB exhibited cytotoxic activities on human cervical cancer cells. Half maximal (IC50) of fractions 1, 2 and 3 on cervical cancer cells were: 35.3 µg/ml, 5.6 µg/ml and 44.4 µg/ml respectively. The IC50 of Fraction 2, 5.6 µg/ml, was statistically significant (P= 0.008) when compared with values obtained from fractions 2 and 3. Conclusion: This study showed that all fractions of YYB exerted cytotoxic activity, but chemical compounds contained in fraction 2 exerted the highest cytotoxicity. Pharmacotherapeutic application of the chemicals as antitumorigenic agent against cervical cancer is discussed.